Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.

Back

HFA Premium Access

Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 5

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor S. Mukhtarova (Tashkent, UZ)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Shakhnoza Mukhtarova

Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)

1 follower

5 more presentations in this session

Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction

Speaker: Doctor S. Mukhtarova (Tashkent, UZ)

Impact of HFpEF in pacemaker patients: a closer look at heart failure events and mortality risk

Speaker: Mrs E. Santos (Vila Nova de Gaia, PT)

Unraveling gender's influence: a detailed analysis of mortality and acute heart failure risk in HFpEF Patients post-pacemaker Implantation

Speaker: Miss E. Santos (Vila Nova de Gaia, PT)

Cardiopulmonary exercise testing in HFpEF patients - a stress-to-rest ratio analyses

Speaker: Doctor K. Franz (Berlin, DE)

Usefulness of the H2PEF score in the stratification of patients with a diagnosis of heart failure with preserved ejection fraction in primary care

Speaker: Miss V. Cendros (ES)

Access the full session

ePosters in chronic heart failure - pathophysiology and mechanisms 5

Speakers: Doctor S. Mukhtarova, Doctor S. Mukhtarova, Mrs E. Santos, Miss E. Santos, Doctor K. Franz...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources